Leukocyte subset-derived genomewide expression profiles in pediatric septic shock

Pediatric Critical Care Medicine

Volumn 11, Issue 3, 2010, Pages 349-355

  Wong, Hector ^a   Freishtat, Robert ^b   Monaco, Marie ^a   Odoms, Kelli ^a   Shanley, Thomas P ^c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

antigen presentation; children; inflammation; microarray; T cell

Indexed keywords

RNA;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ARTICLE; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EPIGENETICS; FEMALE; GENE EXPRESSION PROFILING; GENETIC REGULATION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; INFANT; INNATE IMMUNITY; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; MALE; MONOCYTE; NEUTROPHIL; OBSERVATIONAL STUDY; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RNA ANALYSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UBIQUITINATION; WHOLE CELL;

CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION PROFILING; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; LEUKOCYTES; MALE; OBSERVATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSPECTIVE STUDIES; SHOCK, SEPTIC; SIGNAL TRANSDUCTION; UNITED STATES;

EID: 77952314473     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3181c519b4     Document Type: Article

References (25)

1. Wong HR, Cvijanovich N, Allen GL, et al: Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum. Crit Care Med 2009; 37:1558-1566
2. Wong HR, Shanley TP, Sakthivel B, et al: Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome. Physiol Genomics 2007; 30:146-155
3. Shanley TP, Cvijanovich N, Lin R, et al: Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock. Mol Med 2007; 13:495-508
4. Cvijanovich N, Shanley TP, Lin R, et al: Validating the genomic signature of pediatric septic shock. Physiol Genomics 2008; 34:127-134
5. Wong HR, Cvijanovich N, Wheeler DS, et al: Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock. Am J Respir Crit Care Med 2008; 178:276-282
6. Wong HR: Pediatric septic shock treatment: New clues from genomic profiling. Pharmacogenomics 2007; 8:1287-1290
7. Calvano SE, Xiao W, Richards DR, et al: A network-based analysis of systemic inflammation in humans. Nature 2005; 437:1032-1037
8. Goldstein B, Giroir B, Randolph A: International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6:2-8
9. Pollack MM, Patel KM, Ruttimann UE: The Pediatric Risk of Mortality III-Acute Physiology Score (PRISM III-APS): A method of assessing physiologic instability for pediatric intensive care unit patients. J Pediatr 1997; 131:575-581
10. Irizarry RA, Hobbs B, Collin F, et al: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4:249-264
11. Allison DB, Cui X, Page GP, et al: Microarray data analysis: From disarray to consolidation and consensus. Nat Rev Genet 2006; 7:55-65
12. Chen J, Bardes EE, Aronow BJ, et al: ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res 2009; 37:W305-W311
13. Sun L, Gorospe JR, Hoffman EP, et al: Decreased platelet expression of myosin regulatory light chain polypeptide (MYL9) and other genes with platelet dysfunction and CBFA2/RUNX1 mutation: Insights from platelet expression profiling. J Thromb Haemost 2007; 5:146-154
14. Ayala A, Chaudry IH: Immune dysfunction in murine polymicrobial sepsis: Mediators, macrophages, lymphocytes and apoptosis. Shock 1996; 6(Suppl 1):S27-S38
15. Felmet KA, Hall MW, Clark RS, et al: Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure. J Immunol 2005; 174:3765-3772
16. Hotchkiss RS, Swanson PE, Freeman BD, et al: Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999; 27:1230-1251
17. Hotchkiss RS, Tinsley KW, Karl IE: Role of apoptotic cell death in sepsis. Scand J Infect Dis 2003; 35:585-592
18. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-150
19. Hotchkiss RS, Coopersmith CM, Karl IE: Prevention of lymphocyte apoptosis-A potential treatment of sepsis? Clin Infect Dis 2005; 41(Suppl 7):S465-S469
20. Hotchkiss RS, Osmon SB, Chang KC, et al: Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways. J Immunol 2005; 174:5110-5118
21. Wheeler DS, Zingarelli B, Wheeler WJ, et al: Novel pharmacologic approaches to the management of sepsis: Targeting the host inflammatory response. Recent Pat Inflamm Allergy Drug Discov 2009; 3:96-112
22. Freishtat RJ, Natale J, Benton AS, et al: Sepsis alters the megakaryocyte-platelet transcriptional axis resulting in granzyme B-mediated lymphotoxicity. Am J Respir Crit Care Med 2009; 179:467-473
23. Fabriek BO, van Bruggen R, Deng DM, et al: The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. Blood 2009; 113:887-892
24. Wen H, Schaller MA, Dou Y, et al: Dendritic cells at the interface of innate and acquired immunity: The role for epigenetic changes. J Leukoc Biol 2008; 83:439-446
25. Nadel S, Goldstein B, Williams MD, et al: Drotrecogin alfa (activated) in children with severe sepsis: A multicentre phase III randomised controlled trial. Lancet 2007; 369:836-843